Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region.

ObjectiveTo assess the consistency of the benefits of blood pressure lowering on secondary stroke risk by age, sex and geographic region of recruitment.DesignRandomized, placebo-controlled trial. Participants were randomized to the angiotensin-converting enzyme (ACE) inhibitor perindopril (plus the